Independent from molecular characteristics and TNM staging, CD8+ and CD20+ immuno-gradient indicators, which reflect cell migration towards the tumour, were associated with improved patient survival, while the infiltrative tumour growth pattern was linked to worse patient outcome. The gene discussed is CD8A; the disease is neoplasm.